Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

2.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

966
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
966
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

966
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
966
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seminars in epileptology: Holistic management of epilepsy in adults with intellectual development disorders.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Risk of neurodevelopmental disorders associated with paternal use of valproate during spermatogenesis: a living meta-analysis-version 1.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Folic acid supplementation and prevention of adverse offspring outcomes among women with epilepsy: An observational study.

Epilepsia·2026
Same author

Biallelic variants in RNU2-2 cause a remarkably frequent developmental and epileptic encephalopathy.

Nature genetics·2026
Same author

Timing of high-dose folic acid supplementation in the periconceptional period among women taking antiseizure medications and risk of major congenital anomalies: a target trial emulation.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Polysubstance overdose with cenobamate, levetiracetam and clobazam: Insights into cenobamate toxicity.

Seizure·2026

Related Experiment Video

Updated: Apr 3, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

899

Epilepsy: Intriguing new data on epilepsy and risks at delivery.

Lina Nashef1, Torbjörn Tomson2

  • 1Department of Neurology, King's College Hospital, Denmark Hill, London SE5 9RS, UK.

Nature Reviews. Neurology
|September 16, 2015
PubMed
Summary

Epilepsy in pregnant women significantly increases risks for both mother and fetus. This includes an 11-fold higher risk of maternal death during delivery, warranting careful consideration of these findings.

More Related Videos

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.5K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.7K

Related Experiment Videos

Last Updated: Apr 3, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

899
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.5K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.7K

Area of Science:

  • Obstetrics and Gynecology
  • Neurology
  • Perinatal Medicine

Background:

  • Epilepsy is a common neurological disorder affecting women of reproductive age.
  • Pregnancy in women with epilepsy presents unique challenges for maternal and fetal well-being.
  • Existing data on pregnancy outcomes in epileptic women require further investigation.

Purpose of the Study:

  • To investigate the association between epilepsy and adverse maternal and fetal outcomes during pregnancy and delivery.
  • To quantify the risk of specific adverse events, including maternal mortality, in pregnant women with epilepsy.

Main Methods:

  • Analysis of a large dataset from the USA.
  • Retrospective study design.
  • Comparison of adverse event rates between pregnant women with and without epilepsy.

Main Results:

  • Epilepsy in pregnant women is linked to an elevated risk of adverse outcomes for both mother and fetus.
  • A notable finding includes an 11-fold increase in the risk of maternal death at delivery among women with epilepsy.
  • The study highlights significant perinatal risks associated with epilepsy.

Conclusions:

  • The findings suggest a substantial increase in risks for pregnant women with epilepsy.
  • While intriguing, the study's data necessitate cautious interpretation due to potential confounding factors or limitations.
  • Further research is recommended to validate these findings and explore management strategies.